EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials

Wenxuan Xiong, Jason Roy, Hao Liu, Liangyuan Hu

Contemporary Clinical Trials · 2024

DOI: 10.1016/j.cct.2024.107547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Wenxuan Xiong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA. Electronic address: wx70@sph.rutgers.e…. Hauptthemen laut MEDLINE: Bayes Theorem, Machine Learning, Randomized Controlled Trials as Topic, Research Design. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, National Institutes of Health, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical trials evaluate the safety and efficacy of treatments for specific diseases. Ensuring these studies are well-powered is crucial for identifying superior treatments. With the rise of personalized medicine, treatment efficacy may vary based on biomarker profiles. However, researchers often lack prior knowledge about which biomarkers are linked to varied treatment effects. Fixed or response-adaptive designs may not sufficiently account for heterogeneous patient characteristics, such as genetic diversity, potentially reducing the chance of selecting the optimal treatment for individuals. Recent advances in Bayesian nonparametric modeling pave the way for innovative trial designs that not only maintain robust power but also offer the flexibility to identify subgroups deriving greater benefits from specific treatments. Building on this inspiration, we introduce a Bayesian adaptive design for multi-arm trials focusing on time-to-event endpoints. We introduce a covariate-adjusted response adaptive randomization, updating treatment allocation probabilities grounded on causal effect estimates using a random intercept accelerated failure time BART model. After the trial concludes, we suggest employing a multi-response decision tree to pinpoint subgroups with varying treatment impacts. The performance of our design is then assessed via comprehensive simulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bayes TheoremMachine LearningRandomized Controlled Trials as TopicResearch DesignHumansModels, StatisticalDecision TreesBiomarkers

Stichwörter der Autor:innen

Adaptive randomizationBayesian inferenceMulti-arm multi-stage trialsPersonalized medicineSubgroup finding

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA. Electronic address: wx70@sph.rutgers.edu.
  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA.
  • Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ, USA; Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Förderung

  • NCATS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Xiong, W., Roy, J., Liu, H., & Hu, L. (2024). Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107547

Vancouver

Xiong W, Roy J, Liu H, Hu L. Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2024.107547

BibTeX
@article{Xiong2024,
  author = {Xiong, Wenxuan and Roy, Jason and Liu, Hao and Hu, Liangyuan},
  title = {Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials},
  journal = {Contemporary Clinical Trials},
  year = {2024},
  doi = {10.1016/j.cct.2024.107547}
}
Kostenlos starten →